CAM
HRMY icon

Cresset Asset Management’s Harmony Biosciences HRMY Stock Holding History

Cresset Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Buy
72,435
+5,062
+8% +$166K 0.01% 558
2025
Q4 		$2.52M Buy
67,373
+221
+0.3% +$7.27K 0.01% 504
2025
Q3 		$1.85M Buy
67,152
+315
+0.5% +$10.9K 0.01% 557
2025
Q2 		$2.11M Sell
66,837
-2,124
-3% -$68.3K 0.01% 486
2025
Q1 		$2.29M Sell
68,961
-2,804
-4% -$101K 0.01% 503
2024
Q4 		$2.47M Buy
71,765
+7,557
+12% +$260K 0.01% 492
2024
Q3 		$2.57M Buy
64,208
+3,830
+6% +$135K 0.01% 682
2024
Q2 		$1.82M Buy
60,378
+9,516
+19% +$286K 0.01% 763
2024
Q1 		$1.71M Buy
+50,862
New +$1.63M 0.01% 723

Other funds holding HRMY

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return